| 04.-05. March | Sachs European Life Science CEO Forum, Zurich |
| 23.-25. March | BioSpring & RESI, Lisboa |
| 27.-28. April | BioVaria, Munich |
| 03.-05. May | Swiss Biotech Days, Basel |
| 04.-06. May | BioEquityEurope, Prague |
We look forward to networking with venture capital, business angels and industry leaders, discussing how RIANA’s STAT5 inhibitor program is paving the way for new treatments in oncology. If you’ll be there, we’d love to connect!
RIANA Therapeutics 